Navigation Links
Enzyme and vitamin define the yin and yang of asthma

HOUSTON (March 29, 2009) The allergen breathed in by a person with asthma triggers a proteinase or enzyme called MMP7 that activates a cascade of events to prompt an allergic reaction, said a consortium of researchers led by Baylor College of Medicine ( in Houston in a report that appears online today in the journal Nature Immunology.

In particular, MMP7 activates interleukin 25, a key mediator of the allergic response in the lung said Drs. Farrah Kheradmand ( and David B. Corry (, associate professors of medicine-pulmonary at BCM, and senior authors of the report.

In the same report, the researchers report that they have identified a form of vitamin A made in the lung that is critical for dampening the inflammatory effect. Mice that lack MMP7 were found to have higher production of retinal dehydrogenase, an enzyme that is responsible for synthesizing vitamin A in the lung. MMP7 deficient mice showed less lung inflammation when they are exposed to allergens than did mice who had enough MMP7. Suppressing the production of vitamin A restored the asthmatic symptoms in the MMP7 deficient mice.

"It is important to know which mediators in the airway may be setting off the initial cascade of events that result in the asthmatic reaction in the lung; it would be like getting to the top of the food chain," they said.

In the future, they said, they hope to identify the relationship between the synthesis of vitamin A in the body and the repression of MMP7.


Contact: Dipali Pathak
Baylor College of Medicine

Page: 1

Related medicine news :

1. FDA Warning Letter to Genzyme Related to the Allston Manufacturing Facility
2. Enzyme weakens the heart
3. Durability of dental fillings improves if the enzyme activity of teeth is inhibited
4. Unique Glutathione Reductase Enzyme Introduced by Bio-Research Products
5. Enzyme with a sugar antenna
6. Low Levels of 2 Enzymes in Ovarian Cancer Cells Shortened Survival
7. Millennium Research Group Analyst Available to Comment on FDAs Premarket Approval Recommendation of Genzyme Biosurgerys Synvisc Single-Injection Product for the Knee
8. Scientists ID Enzyme Causing Brain Cell Death
9. Researchers discover new enzyme in cancer growth
10. Broccoli compound targets key enzyme in late-stage cancer
11. IDO2 an active enzyme to target in pancreatic cancer
Post Your Comments:
(Date:10/13/2017)... ... ... While it’s often important to take certain medications during the night, finding ... identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX to ... the need to turn on a light when taking medication during the night, allowing ...
(Date:10/13/2017)... Ill. (PRWEB) , ... October ... ... Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer ... healthcare professionals on guideline updates for the primary prevention of cardiovascular diseases ...
(Date:10/13/2017)... RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... annual Holly Day Market. Featuring a collection of specialty vendors and unique items from ... of personalized and quality-focused health and wellness services offered by the VNA. The ...
(Date:10/13/2017)... ... ... Talented host, actor Rob Lowe, is introducing a segment ... of "Success Files," which is an award-winning educational program broadcasted on PBS Member ... with passion and integrity. , Sciatica occurs when the sciatic nerve in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
Breaking Medicine Technology: